Effect of drug substrates on the reduction of hepatic microsomal cytochrome P-450 by NADPH.
D000632:Aminopyrine; D000814:Aniline Compounds; D000818:Animals; D003580:Cytochromes / Q000378:metabolism*; D005021:Ethylamines; D005260:Female; D006591:Hexobarbital; D007099:Imipramine; D007700:Kinetics; D008099:Liver / Q000378:metabolism*; D008297:Male; D008861:Microsomes / Q000378:metabolism*; D009020:Morphine; D009249:NADP; D009536:Niacinamide; D010084:Oxidation-Reduction; D010860:Pigments, Biological; D011335:Proadifen; D051381:Rats; D012737:Sex Factors; D013053:Spectrophotometry; D014166:Transferases
D000814:Aniline Compounds; D003580:Cytochromes; D005021:Ethylamines; D010860:Pigments, Biological; D000632:Aminopyrine; D009536:Niacinamide; D009249:NADP; D009020:Morphine; D011335:Proadifen; D006591:Hexobarbital; D014166:Transferases; D007099:Imipramine